ସର୍ଭିକାଲ୍ କ୍ୟାନ୍ସର

This is a prospective study to evaluate in-field disease control, survival and late toxicity in patients with cervical cancer or pelvic recurrence treated with spatially fractionated RT. The study will include patients with primary cervical cancer or pelvic recurrence not suitable for brachytherapy in view of anticipated or actual suboptimal target coverage due to aberrant anatomy or large residual disease at the time of brachytherapy.

ସ୍ପୋନ୍ସର: Tata Memorial Hospital
ClinicalTrials.gov ରେ NCT06644846
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 20 Feb 2026 · ଆମେ ପଢ଼ିଲୁ 20 Oct 2026